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H. ST. GEORGE TUCKER, M.D. 
Division of Endocrinology , Department of Medicine, Medical College of Virginia, Health Sciences Division of 
Virginia Commonwealth University, Richmond, Virginia 
Dr. Harold Rifkin*, has previously set forth the 
reasons why we should try to keep the diabetic pa-
tient's blood sugar as near normal as possible. What 
are the generally accepted standards of good diabetic 
control? 
Marble1 considered control of the insulin-depen-
dent diabetic good if the whole blood glucose before 
meals was not over 130 mg% ( = serum glucose 150 
mg%), the 24-hour urinary glucose did not exceed 5% 
of the carbohydrate intake, and there was no keto-
nuria; Oakley et al2 defined satisfactory control as 
blood glucose before meals of less than 150 mg% with 
no hypoglycemia; Lewis et al,3 in a recent paper 
dealing with pregnant diabetics, recommended fast-
ing blood glucose below 100 mg% and blood glucose 
two hours after break fast below 160 mg%. 
In some diabetics we can accomplish this type of 
control; in others we cannot. The maturity onset 
diabetic has some endogenous insulin under auto-
regulatory feedback control and, with a judicious diet 
or with the addition of a sulfonylurea drug or some 
exogenous insulin, near normal blood sugars can be 
achieved. However, in the juvenile or young adult 
onset diabetic, with little or no endogenous insulin, it 
is very difficult, even with complicated schedules of 
administration of insulin, to get blood sugars any-
where near normal without producing hypoglycemia. 
A reasonable goal for every diabetic would be to 
maintain blood sugars as near normal as possible 
without producing hypoglycemia and without requir-
ing a program so restrictive that it interferes with the 
quality of life. 
* see preceding abstract. 
Correspondence and reprint requests to Dr. H . St. George 
Tucker, Division of Endocrinology, Box 111 , Medical College of 
Virginia , Richmond, Virginia 23298. 
MCV QUARTERLY 13(1): 19-23, 1977 
Figure l, taken from a paper by Molnar et al, 4 
illustrates the daily variations in plasma insulin and 
blood glucose throughout a 24-hour period in a nor-
mal individual. Meals, snacks, and standard exercise 
periods are indicated. It is apparent that each feeding 
is accompanied by a sharp peak in insulin secretion 
which brings about disposal of ingested glucose and 
amino acids, and limits the blood sugar rise. 
It is obvious that no one injection of inter-
mediate-acting insulin can in any way duplicate the 
normal insulin pattern. At best an injection ofNPH® 
or Lente® Insulin given before breakfast will be ab-
sorbed for the most part over the next 8 to 12 hours 
when meals will be eaten, with some carry-over effect 
during the night. As diabeticians we hope to accom-
plish blood sugar levels that average ,somewhere near 
normal, but obviously the blood sugar will rise too 
high after meals and .may fall too low before the next 
meal. Further leveling out may be accomplished by 
the addition of between-meal and bedtime snacks. 
We always insist on midafternoon and bedtime 
snacks in every patient on NPH® or Lente® Insulin. 
Bressler and Galloway5 some years ago called 
attention to variations in the timing of effect of vari-
ous insulins (Fig 2). Diabetics were divided into those 
showing a normal (B) response, a transient (A) re-
sponse, or a delayed (C) response to NPH® or Lente® 
Insulin . Those with a normal response could be mod-
erately well regulated with a single morning injection 
of NPH® or Lente® Insulin . Those with a transient 
response might benefit from a second small dose of 
NPH® or Lente® Insulin before supper, and those 
with a delayed response might require the addition of 
regular insulin to the morning dose of NPH® or 
Lente® Insulin. The reasons for this variation in the 
timing of effect of the intermediate-acting insulins is 
not known . One possible factor delaying the action of 
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Fig I-Meal-to-meal <1nd day-to-day variations in blood glucose 
and immunoreactive insulin in a normal subject on two successive 
days (solid line represents first day; interrupted line represents 
second day). B = breakfast, L = lunch, Sk = snack, D = dinner, 
Su = supper, E = exercise, one hour of walking. 
insulin is its binding to antibodies, with subsequent 
release, which prolongs the insulin effect. 
Lukens,6 Forsham, 7 and others pointed out some 
time ago that multiple injections of regular insulin 
before meals, perhaps accompanied by one or more 
injections of longer-acting insulin to control over-
night blood sugar, would more closely resemble nor-
mal physiology and would be likely to give better 
control than a single injection of long- or inter-
mediate-acting insulin. Indeed it is doubtful whether 
the medical profession did diabetic patients any favor 
when some years ago it abandoned multiple insulin 
injections in favor of the once-a-day injection of 
longer-acting preparations. Once the diabetic public 
became accustomed to the single morning injection it 
was difficult to persuade patients to go back to mul-
tiple injections and, by and large, doctors hav~ sel-
dom made the effort. 
Recently there has been a renewal of interest in 
the use of multiple injections of regular insulin to 
accomplish more physiologic control, especially since 
reports from Paris by Job et a1 8 seem to indicate that 
such regimens in juvenile diabetics result in better 
control and in less progression of retinopathy . Also, 
especially good control in pregnant diabetics with 
multiple injections appears to result in lower infant 
mortality and morbidity ,3 although better obstetrical 
techniques for monitoring the pregnancy and timing 
of delivery are equally important factors in the im-
proved outcome in these patiepts. Thus a number of 
schedules of insulin administration have been pro-
posed as illustrated in Table 1. There is good ration-
ale for each of these programs in a given situation, 
although it is unlikely that any one type of program 
will be best for all patients. 
Attempts have been made to define complicated 
dosage schedules even more rigidly. Lewis et al3 rec-
ommend the following formula for insulin adminis-
tration for pregnant diabetics: 
Morning NPH® 
Morning reg . ins. 2: I 
Evening NPH® 
Evening reg. ins. = I : I 
Morning total = 2 X evening total 
I have tried this schedule with several pregnant dia-
betics with quite varied results. I think the reasoning 
is right, but it should be remembered that no two 
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Fig 2-Blood sugar responses to a single daily dose of NPH® 
Insulin. 
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TABLE I 
Various Schedules for Insulin Administration 
Afternoon Bedtime 
Breakfast Lunch Snack Supper Snack 
N 









R + N 
R + N 
(N = _NPH'" or Lente"' Insulin. R = regular or crystalline 
zinc insulin .) 
way-there are just too many variables. Some of 
these are listed in Table 2. 
How then should one approach if)sulin treat-
ment in any given patient? Two basic principles are 
helpful: (I) analyze what kind of diabetic the patient 
is, and (2) keep the variables at a minimum. 
The first principle means to try to form some 
idea of how much endogenous insulin the patient has 
from evaluation of the age of onset of the diabetes, 
his or her weight at onset, and the severity of symp-
toms at onset, especially weight loss . Onset of diabe-
tes early in life, severe polyuria and polydipsia, and 
especially weight loss from uncontrolled diabetes, 
usually indicate total or near total insulin deficiency . 
If the patient has been on treatment, the diabetician 
should also consider the occurrence of ketoacidosjs 
TABLE 2 
Variable Factors Limiting Good Blood Sugar Control 
with Exogenous Insulin 
I. Variation s in food intake 
2. Variations in exercise 
3. Emotional factors and other stresses 
4. Factors a ffecting the availability and effectiveness of 
administered insulin: 
(a ) vari abl e absorption rates from injection site 
(b) variable antibody titers and uncertain rates of release 
of insulin from antibodies 
(c) variations in receptor binding sites a nd in their 
affinity for insulin 
5. Variations in glucagon secretion 
6. Hypoglycemia with rebound hyperglycemia caused by 
counter-regulatory factors 
7. Exogenous insulin is delivered into systemic circulation 
and not primarily into portal circulation and to the liver 
as is endogenously secreted insulin 
or frequent hypoglycemic reactions, both of which 
suggest that the patient has little or no endogenous 
insulin. If the patient has been controlled in the past 
on oral agents he or she must have had some endog-
enous insulin at that time. 
The second principle, keeping the variables at a 
minimum, means trying to get the patient to maintain 
reasonably constant eating habits and exercise pat-
terns as well as simplifying the insulin schedule until 
the need for multiple doses becomes apparent. In 
general , begin with a single dose of NPH® or Lente® 
Insulin every morning, perhaps 20 units if the patient 
has never before taken insulin. Instruct the patient in 
a proper diet, which probably should include both 
afternoon and evening snacks, for his or her weight 
and activity . The patient may continue working but 
should test his or her urine four times daily , before 
meals and at bedtime. If the patient continues to spill 
sugar, increase the insulin by 5 units every four or five 
days until some negative urine tests are obtained. 
Check the blood sugar at the time of the negative 
urine test , and if this is still high, continue to increase 
the insulin until the blood sugar is in the desired 
range. If any hypoglycemic reactions occur, the in-
sulin dose should be reduced . As the patient ap-
proaches control the urine tests should be determined 
from second voidings whenever the first voiding con-
tains sugar. 
Many diabetics will come under satisfactory 
control with a single morning dose of NPH® or 
Lente@ Insulin. If glycosuria or hyperglycemia per-
sists before breakfast, with negative tests in the after-
noon, the patient may be classified as a transient 
responder, and a second small dose of N PH® or 
Lente''9 Insulin should be added before supper. If the 
morning test is repeatedly negative but glycosuria 
persists before lunch, the patient may be a delayed 
responder, and regular insulin can be added to the 
morning NPH@. 
If the desired degree of control is not achieved by 
these measures, both regular and NPH® Insulin may 
be given twice daily . In general the indications for 
administration of such multiple doses would follow a 
schedule such as in Table 3, as suggested by Oakley et 
al. 2 
In a highly reliable and highly motivated patient, 
such as a pregnant diabetic, this type of program may 
succeed ; or a highly obsessive patient may religiously 
seek perfect i:.;ontrol. Unfortunately most patients are 
not so reliable, and the obsessive ones usually end up 
making themselves hypoglycemic. 
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TABLE 3 
Management of the Severe Diabetic with Twice Daily 
Injections of Re~ular and NPH® Insulin 
Timing of urine or 
Peridd of blood sugar for 
Insulin Maximum Action dose adjustment 
Morning RI Breakfast to lunch Pre-lunch 
Morning NPH® Lunch to supper Pre-supper 
Evening RI Supper to midnight Bedtime 
Evening NPH '"' Midnight to breakfast Pre-breakfast 
What do you do with the patient who never 
shows any consistent pattern? You look for such 
variables as food intake, exercise, emotional upsets, 
and other factors . Hypoglycemia, recognized or un-
recognized, is the cause of much brittleness. For ev-
ery recognized hypoglycemic reaction, the brittle 
juvenile diabetic has ten other occasions when the 
blood sugar is quite low without his knowledge, and 
each may be followed by rebound hyperglycemia. 
You must learn to recognize this pattern and to re-
duce insulin accordingly. Tables 4 and 5 illustrate two 
such patients. 
Table 4 is a record of the urine sugars on a 23-
year-old dental student with diabetes of two years' 
duration, during which he took 12 units of Semi-
lente® and 20 units of Lente® Insulin daily. He was on 
a 2500-calorie diet including three main meals and 
midafternoon and bedtime snacks. He was extremely 
conscientious and liked to keep all his urine tests 
negative. To keep himself in physical trim he ran two 
TABLE 4 
Insulin Dosage and Urine Tests Showing Glycosuria 
Following Asymptomatic and Unrecognized Hypoglycemia 
J.S. (Male, 23) Urine sugars 
Insulin 7 II 4 9 
12 SL ± 20 L N N N N 
N N N N* 
4 + 4+ N N 
N N N N* 
2+ 3+ N N 
N 3+ N N* 
3+ N N 4 + 
4 + I+ N N 
N N N N 
• Ran approximately 2 miles 
(SL = Semilente® Insulin. L = Lente® Insulin .) 
miles several times a week, and because of his busy 
schedule chose the late evening as the time for his 
exercise. He was not conscious of any hypoglycemic 
reactions, but he invariably showed unexpected sugar 
in his urine on the mornings after running; when he 
had not run the night before, his tests were almost all 
negative. It became apparent that the additional exer-
cise was causing undetected hypoglycemia during the 
night, followed by rebound hyperglycemia and glyco-
suria the next day, the so-called Somogyi effect 
caused by the secretion of epinephrine, glucagon, cor-
tisol, and growth hormone in response to hypogly-
cemia. The situation was corrected by insisting that 
he take sizable extra feedings just before and just 
after his nocturnal exercise periods; this prevented 
the hypoglycemia and its consequent rebound. 
The Somogyi rebound hyperglycemia following 
hypoglycemia is most often seen in the brittle juvenile 
diabetic, but can be observed in any insulin-depen-
dent diabetic. Table 5 shows the record of urine tests 
on a 72-year-old diabetic taking 32 units of NPH® 
Insulin daily. He also was very conscientious and 
very careful about his diet. After a series of days with 
all negative urine tests, he showed unexpected 4+ 
sugar at noon on Aug 29 and Aug 30, with sugar 
TABLE 5 
Insulin Dosage and Urine Tests in an Older Diabetic 
Showing Glycosuria, Probably Representing Rebound 
After Unrecognized Hypoglycemia 
J.Y.C. (Male, 72) 
NPH® 7 12 5 9 
8/ 27 32 N N N 4 + 
8/ 28 N N N N 
8/ 29 N 4+ I + 3+ 
8/ 30 N 4 + 4 + 4 + 
8/ 31 30 N N N N 
9/ 1 N tr tr N 
9/ 2 N N 3+ 3+ 
9/ 3 tr tr N 4 + 
9/ 4 N N N N 
9/ 5 N N N N 
9/ 6 N N N N 
9/7 N N N N 
9/ 8 N tr tr 4 + 
9/ 9 N 2+ N 3+ 
9/ 10 3+ 3+ N 4 + 
9/ 11 N 2+ 4 + 4 + 
9/ 12 3+ tr N N 
9/ 13 I + 3+ N N 
9/ 14 N N N N 
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persisting during the rest of the day. Questioning 
revealed no dietary indiscretions, no variation in ex-
ercise, and no emotional upsets or other stresses to 
account for the glycosuria. Although he was unaware 
of any hypoglycemic symptoms, it seemed inconceiv-
able that the dose of insulin which had kept his tests 
all negative over the previous days could be so in-
adequate on these days. I suspected unrecognized 
hypoglycemia and reduced his NPH® Insulin to 30 
units. The urine tests improved and remained all 
negative until Sep 8 when he again began to show 
sugar in the evening test. Not shown in Table 5 is the 
fact that his NPH® Insulin was lowered again to 28 
units and later to 26 units with improvement each 
time and, finally, all negative urine tests. He remained 
on 26 units of NPH® for several months, then began 
to spill sugar in all specimens; the NPH® Insulin dose 
has been gradually raised again to 30 units with good 
control. The reason for these swings in insulin re-
quirement over periods of several months is un-
known. Some patients go through cycles when their 
insulin requirement goes up or down for no apparent 
reason; these may be over months or over shorter 
periods. All we can do is to try to keep pace through 
adjustments in insulin dose. 
When the patient alternates between good days 
and bad days, with lots of sugar or no sugar, suspect 
hypoglycemia with rebound. In any event you should 
adjust the patient's insulin dose to his or her better 
days and not try to give more for the bad days or you 
will surely produce hypoglycemia. 
The bane of the diabetician 's existence is the 
obese patient on insulin. If these patients could have 
been made to reduce in the beginning, many of them 
would not have needed insulin. Once on insulin, li-
polysis is inhibited, weight reduction becomes even 
more difficult, and these patients tend to gain more 
weight which increases insulin resistance, creating a 
vicious circle of upward spiraling weight and insulin 
dosage. In this instance it may be better to cut back 
the insulin dosage and let the patient spill sugar until 
somehow he or she can be persuaded to really limit 
food intake. There is no satisfactory answer to this 
problem unless the patient loses weight. 
In summary, I believe in aiming for the best 
possible control for each patient through an empir-
ical approach which seeks to arrive at the best sched-
ule for the individual patient. We want especially 
tight control for the pregnant diabetic, and for this 
patient it is likely that multiple insulin injections are 
needed. If further experience confirms the benefits of 
multiple injections for juvenile patients, this type of 
treatment may a1so be indicated for these patients. 
Figure I is reproduced with permission from Mayo Clinic 
Proceedings (47:709-719, 1972). 
Figure 2 is reproduced with permission from Medical Clinics 
of North America (55:861-868, 1971 ). 
Table 3 is reproduced with permission from Diabetes 
( 15:219-222, 1966). 
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